Is my antihistamine safe?

Home Care Provider

Volumn 2, Issue 3, 1997, Pages 117-120

  Ashworth, Laurel ^a,b  

^a Drug Information Center   (United States)

^b MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; DRUG DERIVATIVE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; TERFENADINE;

DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; PATIENT SELECTION; REVIEW; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HISTAMINE ANTAGONISTS; HISTAMINE H1 ANTAGONISTS; HUMANS; PATIENT SELECTION; TERFENADINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0031154796     PISSN: 1084628X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-628X(97)90134-9     Document Type: Note

References (25)

1. Cruzan SM. FDA talk paper [cited 13 January 1997]. Available at http://www.fda.gov/bbs/topics/ANSWERS/ANS00780.html
2. Fexofenadine. Med Lett Drug Ther 1996;38(986):95-6.
3. Hebel SK, publisher. Facts and comparisons. St. Louis (MO): Facts and Comparisons; 1993: p. 188.
4. Masheter HC. Terfenadine: the first nonsedating antihistamine. Clin Rev Allergy Immunol 1993;11:5-34.
5. The top 200 drugs. American Druggist 1997;214(2):30-7.
6. Mathews DR, McNutt B, Okerholm R, Flicker M, McBride G. Torsades de pointes occurring in association with terfenadine use. JAMA 1991;266:2375-6.
7. Crane JK, Shih H-T Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine. Am J Med 1993;95:45-6.
8. Product information. Seldane brand of terfenadino. Hoechst Marion Roussel, Kansas City (MO); 1995.
9. Product information. Hismanal brand of astemizole. Janssen Pharmaceutica, Titusville (NJ); 1993.
10. Cupp MJ, Tracy TS. Role of the cytochrome P450 3A subfamily in drug interactions. US Pharmacist 1997;22:HS9-21.
11. Product information. Claritin brand of loratadine. Schering Corp., Kenilworth (NJ); September 1995.
12. Product information. Allegra brand of fexofenadine. Hoechst Marion Roussel, Kansas City (MO); August 1996.
13. Slaughter RI, Edwards DJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995;29:619-24.
14. Murray M, Reidy GF. Selectivity in the inhibition of mammalian cytochromes P450 by chemical agents. Pharmacol Rev 1990;42:85-101.
15. Krishna D, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994;26:144-60.
16. Yun C, Okerholm RA, Guengerich FP. Oxidation of the antihistaminic drug terfenadine in the human liver microsomes: role of cytochrome P450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 1992;21:403-9.
17. Honig PK, Woosley RL, Zamani K, Conner D, Cantilena L. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
18. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA 1993;269:1513-8.
19. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-6.
20. Monahan BP, Ferguson CL, Kileavy ES, Lloyd BK, Troy J, Cantilena LR. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-90.
21. Woosley RL, Chen Y, Pinney SP. Terfenadine and cardiac death, J Allergy Clin Immurol 1993;91:262.
22. Ketter TA, Flockhart DA, Post RM. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 1995;15:387-98.
23. Von Moltke LL, Greenblatt DJ, Duan SX, Harmatz JS, Wright CE, Shader RI. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo. J Clin Psychopharmacol 1996;16:104-12.
24. Haria M, Fitton A, Peters DH. Loratadine: a reappraisal of its pharmacological properties and therapeutic uses in allergic disorders. Drugs 1994;48:617-37.
25. Honig P, Wortham D, Lazarev A, Cantilena LR. Grapefruit juice alters the systemic bioavailabilily and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 1996;36:345-51.